Hepatitis B vaccine for infants of HBsAg-positive mothers

American Family Physician

Volumn 75, Issue 1, 2007, Pages 50-51

  Kripke, Clarissa ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; HEPATITIS B(E) ANTIGEN;

CLINICAL TRIAL; DRUG DOSE REGIMEN; DRUG POTENTIATION; HEPATITIS B; HUMAN; INFECTION RISK; MATERNAL CARE; NEWBORN CARE; NOTE; VIRUS TRANSMISSION;

EID: 33846077555     PISSN: 0002838X     EISSN: 0002838X     Source Type: Journal    
DOI: None     Document Type: Note

References (2)

1. Wong VC, Ip HM, Reesink HW, Lelie PN, Reerink-Brongers EE, Yeung CY, et al. Prevention of the HBsAg carrier state in newborn infants of mothers who are chronic carriers of HBsAg and HBeAg by administration of hepatitis-B vaccine and hepatitis-B immunoglobulin. Double-blind randomised placebo-controlled study. Lancet 1984;1:921-6.
2. Mast EE, Margolis HS, Fiore AE, Brink EW, Goldstein ST, Wang SA, et al. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) part 1: immunization of infants, children, and adolescents [Published correction appears in MMWR Morb Mortal Wkly Rep 2006;55:158-9]. MMWR Recomm Rep 2005;54(RR-16):1-23. Accessed October 24, 2006, at: http://www.cdc.gov/MMWR/preview/mmwrhtml/rr5416a1.htm.